Back
Verrica Pharmaceuticals Vs. Monopar Therapeutics Industry Stock Comparison
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
$0.47
Seasonality Move:
-3.06%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.52. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 36.43 | Sell |
Chaikin Money Flow: | -354339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.7) | Sell |
Bollinger Bands (100): | (0.56 - 1.08) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -4864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.9 - 41.16) | Buy |
Bollinger Bands (100): | (18.89 - 38.95) | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Sell |
20-day SMA: | 0.62 | Sell |
50-day SMA: | 0.66 | Sell |
200-day SMA: | 2.77 | Sell |
8-day EMA: | 0.59 | Sell |
20-day EMA: | 0.62 | Sell |
50-day EMA: | 0.7 | Sell |
200-day EMA: | 2.21 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.16 | Buy |
20-day SMA: | 33.55 | Buy |
50-day SMA: | 36.72 | Buy |
200-day SMA: | 16.35 | Buy |
8-day EMA: | 37.12 | Buy |
20-day EMA: | 35.96 | Buy |
50-day EMA: | 34.41 | Buy |
200-day EMA: | 21.02 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.16 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Verrica Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |